(Q39258887)

10 September 2017

title

Combination of intrathecal opioids with bupivacaine attenuates opioid dose escalation in chronic noncancer pain patients (English)

1 reference

10 September 2017

0 references

0 references

I Elias Veizi

1

1 reference

10 September 2017

Salim M Hayek

2

1 reference

10 September 2017

Samer Narouze

3

1 reference

10 September 2017

Jason E Pope

4

1 reference

10 September 2017

Nagy Mekhail

5

1 reference

10 September 2017

publication date

21 September 2011

1 reference

10 September 2017

1 reference

10 September 2017

volume

12

1 reference

10 September 2017

issue

10

1 reference

10 September 2017

page(s)

1481-1489

1 reference

Polyanalgesic Consensus Conference 2003: an update on the management of pain by intraspinal drug delivery-- report of an expert panel

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Understanding the physiology and pharmacology of epidural and intrathecal opioids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Outcome of intrathecal opioids in chronic non-cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Intrathecal opioid therapy for chronic nonmalignant pain: a retrospective cohort study with 3-year follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Continuous intrathecal morphine treatment for chronic pain of nonmalignant etiology: long-term benefits and efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Intraspinal morphine for chronic pain: a retrospective, multicenter study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Age-dependent opioid escalation in chronic pain patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Long-term intrathecal opioid therapy with a patient-activated, implanted delivery system for the treatment of refractory cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Opiate pharmacology of intrathecal granulomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

A differential diagnosis of hyperalgesia, toxicity, and withdrawal from intrathecal morphine infusion

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Polyanalgesic consensus conference 2007: recommendations for the management of pain by intrathecal (intraspinal) drug delivery: report of an interdisciplinary expert panel

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Role of Spinal Opioid Receptors in the Antinociceptive Interactions Between Intrathecal Morphine and Bupivacaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

21 January 2018

Intrathecal analgesia

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Long-term intrathecal infusion of drug combinations for chronic back and leg pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Continuous intrathecal morphine infusion in patients with vertebral fractures due to osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Intrathecal opioid treatment for chronic non-malignant pain: a 3-year prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

A prospective study of long-term intrathecal morphine in the management of chronic nonmalignant pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Intrathecal morphine infusion for chronic non-malignant pain: a multiple center retrospective survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Opioid inhibition of Ih via adenylyl cyclase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Clinical experience with intrathecal bupivacaine in combination with opioid for the treatment of chronic pain related to failed back surgery syndrome and metastatic cancer pain of the spine

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Stability, compatibility, and safety of intrathecal bupivacaine administered chronically via an implantable delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Use of intrathecal bupivacaine in refractory chronic nonmalignant pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Efficacy of intrathecal bupivacaine: how important is the flow rate?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

Intrathecal coadministration of bupivacaine diminishes morphine dose progression during long-term intrathecal infusion in cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1526-4637.2011.01232.X

10.1111/J.1526-4637.2011.01232.X

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference